HemorrhageREBOASIMNCT05062928
Mixed-reality REBOA Simulator With Virtual Coaching
A study testing Virtual coach in people with Hemorrhage and Simulation Training, run by University of Florida at 1 site in United States.
Trial summary
Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is a life-saving emergency procedure that is highly suited for simulation-based training. This study aims to assess the validity of our REBOA simulator with virtual coach (or live quantitative feedback) for mastery learning. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Hemorrhage, Simulation Training
- What is being tested?
- Virtual coach
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 14 participants
- Where
- 1 siteUnited States
- Study dates
- 10 Feb 2022to 11 Nov 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- >18 years of age
Who cannot join
- i. not obtaining informed consent,
- ii. inability to complete all the procedures,
- iii. Completed a REBOA course iv. Used the US-guided REBOA simulator in any way
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Assessment of a Mixed-reality Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) Training Simulator With Virtual Coach for Mastery Learning.
Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is a life-saving emergency procedure that is highly suited for simulation-based training.
This study aims to assess the validity of our REBOA simulator with virtual coach (or live quantitative feedback) for mastery learning.
Read more
The hypotheses are:
H0: Virtual coach is non-inferior in REBOA training to an average human instructor.
H1: Virtual coach is inferior in REBOA training to an average human instructor. We expect to learn whether the virtual coach is non-inferior to an average human instructor for US-guided REBOA training. Additionally, we expect to find which determinants affect success rate most and to assess the needs for the current simulator system's future software development.
Read the detailed description
Methods:
Study design: This is a multi-center randomized simulation study. Setting, location, participants: This multi-center study will be held at University of Florida (UF) Health and Madigan Health centers. Planned time is between June 01 to October 31, 2021. The study population will be trainees (students, residents, fellows, and physicians) working at UF Health Center and Madigan Health Center. Exclusion criteria are: i. not obtaining informed consent, ii. inability to complete all the procedures.
Timeframe of training and data collection: June 01 to October 31, 2021 Learner or trainee population: Learners will be healthcare staff in two hosting institutions. Trainers will be the academic staff from UF Health and Madigan Medical Center.
Measurements:
Development and pilot testing of assessment tool: REBOA simulator will be developed at the Center for Safety, Simulation, and Advanced Learning Technologies (CSSALT). Pilot testing will be on primary team members. The trainer will play confederate nurse role and assist the participant.
Psychometric properties of previously developed and pilot tested tools: The hosting center (CSSALT) has developed a central venous access (CVA) simulator with a virtual coach. The same simulator development technology (SMMARTS) will be used in the proposed project. Study team has prior data regarding psychometric properties of previously developed simulators.
Rater training to use assessment tools and scores consistently: The simulator has a limit for the number of instruments (4) to be tracked. Therefore, the it will track the procedures that occur under the skin out of a human instructor's sight by the simulator's software, whereas the procedures that are visible by the trainers are not automatically tracked by the software. There will therefore be two rating systems: One is by trainers or assistants (T) and the other is by the simulator's software (SS). Rating by SS will be electronically and automatically scored. The study team will train the in-person trainers prior to study to score the learners consistently. For this purpose, the study will plan an online training for trainers prior to the data collection phase to obtain consistent rating of the participants. Based on the current literature, ratings will be based on these items and rating systems, which are given in parentheses for each item:
- Sheath insertion with Seldinger technique i. Sheath priming (T) ii. Ultrasound-guided puncture (SS) iii. Sheath guidewire insertion (T) iv. Sheath insertion: Participants receive "fail" grade if they did not complete this item successfully to common femoral artery (CFA) or inserted to the common femoral vein (CFV) (SS) b. Balloon insertion i. Balloon priming (T and SS) ii. Balloon test: Participants receive "fail" grade if they inflated the balloon during preparation (T and SS) iii. Balloon position measurement using body landmarks (SS) iv. Balloon inflation (SS) v. Final balloon position (SS)
In addition to the reported items above, we will track several items to build a better training system. The virtual coaching system of the SMMARTS simulator will automatically capture and store the data required for the study including:
- Balloon inflation volume: We developed a syringe simulator system. (SS) b. Inflation of the balloon with saline [Zone 1: 8 mL (cc) Zone 3: 2 mL (cc)] (SS) c. Observe the simulated blood pressure monitor to see the increase of the blood pressure. (SS) d. Timeframes (SS) e. Back walling (SS) f. Precise discrimination of the Zone where the balloon was inflated. (SS) g. Puncturing: i. Needle tip remains in femoral artery from time of arterial access to guidewire placement (SS) ii. Needle tip completely in US plane at time of arterial puncture. (SS) iii. Needle angle to the skin surface at vascular access. (SS) iv. Advancing needle while the tip is outside the ultrasound insonation plane. (SS)
Standard setting methodology
Clear definition of mastery: Mastery is defined as two consecutive successful applications of Prytime REBOA catheter in two different Zones; one is for Zone 1 and the other is to Zone 3. Using right or left groin does not matter. The participant can apply on the same side, or do the second try using the other side.
Description of scoring rules: Scoring will be based on the measurements by the simulator software and ratings by trainer. These items include but are not limited to:
Clear definition of how minimum passing standards were set: Minimum passing standards are set as:
Insert two REBOA catheters Without complications (venous puncture, inflating balloon in wrong zone or volume) Within 240 seconds from hitting the start button to secure the REBOA Interventions
Detailed description of curriculum development including:
Teaching tools: An experienced clinician will be the instructor with online training. The instructor will explain the study and simulator through an online presentation to the participants. Volunteers will sign the informed consent if they agree to participate. The instructor will present an online didactic course to participants. Online training will be recorded and available to the participants at any stage of the study for their reference. Then participants will take the "Guay Visualization of Views Test" (limited to 8 minutes) to assess their spatial abilities. Afterwards, participants will start hands-on training. One simulator will be set up in a specific room for the study with the required equipment. Participants will practice one-by-one, and they will be able to schedule hands-on training time based on mutual availability of the instructor and participant. The training intervention is expected to be completed in 4 months. Every participant will practice until mastery is achieved. (see Figure 1). There will be no control group.
Participants will be randomized into two groups (see Figure 1) with a simple randomization using a random number table. One group will be trained by an average human instructor and the other group will be trained by the virtual coach. In some institutions like UF, there are scoring systems for the assessment of instructors, e.g., by residents. Some instructors are excellent, but some are not. The instructor's performance may affect the results of the simulation studies. Therefore the study proposes to include instructors within the normal ranges of assessment (not the worst or the best) and term them as 'average instructor.' Baseline assessment: First try of the participants at placing a REBOA on the simulator will be the baseline measurement.
Nature of practice (e.g. duration, intensity, individuals or team): The hands-on training session to mastery is expected to be under 3 hours for each participant.
Feedback/debriefing (source, type, frequency): After each try, the instructor or virtual coach will provide feedback and a 3-minute debriefing based on the simulator's software measurements.
Post-training assessment with minimum passing standards (MPS): After every try, the trainer and the simulator's software will report the participant's score based on MPS Stakes for participants: During the COVID-19 pandemic, participants run the risk of infection during training. We will conduct online orientation and didactic training via cloud-based video communications apps. Participants will undergo hands-on training sessions individually. If the pandemic is not resolved, both instructor and trainee will stay 6 feet apart and use face covers. Hands-on training may also be risky for COVID-19 infection. Participants will take the training one-by-one and clean the simulator with disinfectant after completing the training. The simulator and the handheld tools will be cleaned and wiped down with 55% Isopropyl Alcohol between participants. This study will be voluntary. If a trainee or a staff member opts not to participate, they will not be penalized in any way.
Outcome measures
Primary outcome is to evaluate the non-inferiority of the REBOA simulator with a virtual coach.
Secondary outcomes are:
- Define the time required for a complete REBOA insertion on a simulator ii. Define the time required the time to mastery iii. Define the complication rates in the simulator iv. Association of success rates and complications on the simulator to spatial ability
Sample size: The study conducted a power analysis/sample size calculation for a non-inferiority analysis on the difference in two independent proportions, assuming α=.05, power=.95, a high success rate expected for both groups (99%) and a non-inferiority margin of 15% (https://www.sealedenvelope.com/power/binary-noninferior/ [Accessed March 26, 2021]). Sample size required per group is 10. The investigators decided to include a total of 28 participants to the study. The non-inferiority margin is set so that a difference bigger than this limit would matter in clinical practice. It is usually assumed that the success proportion is the same in both groups unless there is good reason to believe that one treatment is, in fact, superior.
Statistical methods
Descriptive analyses: The investigators will use SPSS for statistical analysis. Yahya A. Acar, MD, will perform the analysis. Demographic data will be presented as frequencies and percentages. Continuous variables will be presented as mean and standard deviation.
Analyses used to assess: The chi-square test will be used for the comparison of two groups concerning categorical variables. Wilcoxon signed-rank test and the dependent t-test will be used for pairwise comparisons (first and last measurements) of continuous data that do not conform to a normal distribution. Logistic regression analysis will be used to identify factors independently predictive of success. Those factors remaining in the model will be used in a set of linear scores. Receiver operating characteristic curves (ROC) will be constructed for each model, and the areas under the curve will be calculated.
- Conditions
- Hemorrhage, Simulation Training
- Being tested
- Virtual coach
- Keywords
- aorta, abdominal, aorta, thoracic, Teaching
- Medical subject headings
- Hemorrhage
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Virtual coachOther
This group will be trained and assessed by the virtual coach.
| Study group | Role | What they receive |
|---|---|---|
| Virtual coaching group | Experimental | In this group, the virtual coach will train and assess. Receives: Other: Virtual coach |
| Human instructor group | No intervention | In this group, a human instructor will train, but the virtual coach will assess. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Virtual coach is non-inferior in REBOA training to an average human instructor
The study will compare the virtual coach group and human instructor groups by means of reaching to mastery. Mastery is defined as two consecutive successful REBOA insertion to zone 1 and zone 2. The investigators defined the success criteria in the methods section in detail.
Measured: 2 hours
Secondary outcomes (3)
Define the time required for a complete REBOA insertion on a simulator
The study will calculate the total time for the REBOA insertion in the simulator from start to finish.
Measured: 2 minutes
Define the time required the time to mastery
Secondary outcome
Measured: 2 hours
Association of success rates and complications on the simulator to spatial ability
The investigators will use Guay spatial orientation test and the complications occurred during the assessment phase for the assessment of this secondary outcome.
Measured: 8 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Sep 2021
- Study start10 Feb 2022
- Primary completion11 Apr 2022
- Study completion11 Nov 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HemorrhageStudies of the same condition, open and under way.
- More trials run by University of FloridaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 14 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Florida
- Sponsor type
- University, hospital or other
- Collaborators
- Madigan Army Medical Center
- Responsible party
- Sponsor
- Investigators
- Samsun Lampotang, Study director, Univeristy of Florida
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05062928
- Sponsor's protocol ID
- IRB202101271
- Acronym
- REBOASIM
- Status last verified
- Nov 2025
- First submitted
- 21 Sep 2021
- Last updated
- 20 Nov 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of a Mixed-reality Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) Training Simulator With Virtual Coach for Mastery Learning.
- ClinicalTrials.gov ID
- NCT05062928
- Acronym / sponsor ID
- REBOASIM / IRB202101271
- Conditions
- Hemorrhage, Simulation Training
- Keywords
- aorta, abdominal, aorta, thoracic, Teaching
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 14 participants (actual)
- Lead sponsor
- University of FloridaUniversity, hospital or other
- Collaborators
- Madigan Army Medical Center
- Study start
- 10 Feb 2022 (actual)
- Primary completion
- 11 Apr 2022 (actual)
- Study completion
- 11 Nov 2022 (actual)
- First posted
- 30 Sep 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is a life-saving emergency procedure that is highly suited for simulation-based training.
This study aims to assess the validity of our REBOA simulator with virtual coach (or live quantitative feedback) for mastery learning.
The hypotheses are:
H0: Virtual coach is non-inferior in REBOA training to an average human instructor.
H1: Virtual coach is inferior in REBOA training to an average human instructor. We expect to learn whether the virtual coach is non-inferior to an average human instructor for US-guided REBOA training. Additionally, we expect to find which determinants affect success rate most and to assess the needs for the current simulator system's future software development.
Detailed description
Methods:
Study design: This is a multi-center randomized simulation study. Setting, location, participants: This multi-center study will be held at University of Florida (UF) Health and Madigan Health centers. Planned time is between June 01 to October 31, 2021. The study population will be trainees (students, residents, fellows, and physicians) working at UF Health Center and Madigan Health Center. Exclusion criteria are: i. not obtaining informed consent, ii. inability to complete all the procedures.
Timeframe of training and data collection: June 01 to October 31, 2021 Learner or trainee population: Learners will be healthcare staff in two hosting institutions. Trainers will be the academic staff from UF Health and Madigan Medical Center.
Measurements:
Development and pilot testing of assessment tool: REBOA simulator will be developed at the Center for Safety, Simulation, and Advanced Learning Technologies (CSSALT). Pilot testing will be on primary team members. The trainer will play confederate nurse role and assist the participant.
Psychometric properties of previously developed and pilot tested tools: The hosting center (CSSALT) has developed a central venous access (CVA) simulator with a virtual coach. The same simulator development technology (SMMARTS) will be used in the proposed project. Study team has prior data regarding psychometric properties of previously developed simulators.
Rater training to use assessment tools and scores consistently: The simulator has a limit for the number of instruments (4) to be tracked. Therefore, the it will track the procedures that occur under the skin out of a human instructor's sight by the simulator's software, whereas the procedures that are visible by the trainers are not automatically tracked by the software. There will therefore be two rating systems: One is by trainers or assistants (T) and the other is by the simulator's software (SS). Rating by SS will be electronically and automatically scored. The study team will train the in-person trainers prior to study to score the learners consistently. For this purpose, the study will plan an online training for trainers prior to the data collection phase to obtain consistent rating of the participants. Based on the current literature, ratings will be based on these items and rating systems, which are given in parentheses for each item:
- Sheath insertion with Seldinger technique i. Sheath priming (T) ii. Ultrasound-guided puncture (SS) iii. Sheath guidewire insertion (T) iv. Sheath insertion: Participants receive "fail" grade if they did not complete this item successfully to common femoral artery (CFA) or inserted to the common femoral vein (CFV) (SS) b. Balloon insertion i. Balloon priming (T and SS) ii. Balloon test: Participants receive "fail" grade if they inflated the balloon during preparation (T and SS) iii. Balloon position measurement using body landmarks (SS) iv. Balloon inflation (SS) v. Final balloon position (SS)
In addition to the reported items above, we will track several items to build a better training system. The virtual coaching system of the SMMARTS simulator will automatically capture and store the data required for the study including:
- Balloon inflation volume: We developed a syringe simulator system. (SS) b. Inflation of the balloon with saline [Zone 1: 8 mL (cc) Zone 3: 2 mL (cc)] (SS) c. Observe the simulated blood pressure monitor to see the increase of the blood pressure. (SS) d. Timeframes (SS) e. Back walling (SS) f. Precise discrimination of the Zone where the balloon was inflated. (SS) g. Puncturing: i. Needle tip remains in femoral artery from time of arterial access to guidewire placement (SS) ii. Needle tip completely in US plane at time of arterial puncture. (SS) iii. Needle angle to the skin surface at vascular access. (SS) iv. Advancing needle while the tip is outside the ultrasound insonation plane. (SS)
Standard setting methodology
Clear definition of mastery: Mastery is defined as two consecutive successful applications of Prytime REBOA catheter in two different Zones; one is for Zone 1 and the other is to Zone 3. Using right or left groin does not matter. The participant can apply on the same side, or do the second try using the other side.
Description of scoring rules: Scoring will be based on the measurements by the simulator software and ratings by trainer. These items include but are not limited to:
Clear definition of how minimum passing standards were set: Minimum passing standards are set as:
Insert two REBOA catheters Without complications (venous puncture, inflating balloon in wrong zone or volume) Within 240 seconds from hitting the start button to secure the REBOA Interventions
Detailed description of curriculum development including:
Teaching tools: An experienced clinician will be the instructor with online training. The instructor will explain the study and simulator through an online presentation to the participants. Volunteers will sign the informed consent if they agree to participate. The instructor will present an online didactic course to participants. Online training will be recorded and available to the participants at any stage of the study for their reference. Then participants will take the "Guay Visualization of Views Test" (limited to 8 minutes) to assess their spatial abilities. Afterwards, participants will start hands-on training. One simulator will be set up in a specific room for the study with the required equipment. Participants will practice one-by-one, and they will be able to schedule hands-on training time based on mutual availability of the instructor and participant. The training intervention is expected to be completed in 4 months. Every participant will practice until mastery is achieved. (see Figure 1). There will be no control group.
Participants will be randomized into two groups (see Figure 1) with a simple randomization using a random number table. One group will be trained by an average human instructor and the other group will be trained by the virtual coach. In some institutions like UF, there are scoring systems for the assessment of instructors, e.g., by residents. Some instructors are excellent, but some are not. The instructor's performance may affect the results of the simulation studies. Therefore the study proposes to include instructors within the normal ranges of assessment (not the worst or the best) and term them as 'average instructor.' Baseline assessment: First try of the participants at placing a REBOA on the simulator will be the baseline measurement.
Nature of practice (e.g. duration, intensity, individuals or team): The hands-on training session to mastery is expected to be under 3 hours for each participant.
Feedback/debriefing (source, type, frequency): After each try, the instructor or virtual coach will provide feedback and a 3-minute debriefing based on the simulator's software measurements.
Post-training assessment with minimum passing standards (MPS): After every try, the trainer and the simulator's software will report the participant's score based on MPS Stakes for participants: During the COVID-19 pandemic, participants run the risk of infection during training. We will conduct online orientation and didactic training via cloud-based video communications apps. Participants will undergo hands-on training sessions individually. If the pandemic is not resolved, both instructor and trainee will stay 6 feet apart and use face covers. Hands-on training may also be risky for COVID-19 infection. Participants will take the training one-by-one and clean the simulator with disinfectant after completing the training. The simulator and the handheld tools will be cleaned and wiped down with 55% Isopropyl Alcohol between participants. This study will be voluntary. If a trainee or a staff member opts not to participate, they will not be penalized in any way.
Outcome measures
Primary outcome is to evaluate the non-inferiority of the REBOA simulator with a virtual coach.
Secondary outcomes are:
- Define the time required for a complete REBOA insertion on a simulator ii. Define the time required the time to mastery iii. Define the complication rates in the simulator iv. Association of success rates and complications on the simulator to spatial ability
Sample size: The study conducted a power analysis/sample size calculation for a non-inferiority analysis on the difference in two independent proportions, assuming α=.05, power=.95, a high success rate expected for both groups (99%) and a non-inferiority margin of 15% (https://www.sealedenvelope.com/power/binary-noninferior/ [Accessed March 26, 2021]). Sample size required per group is 10. The investigators decided to include a total of 28 participants to the study. The non-inferiority margin is set so that a difference bigger than this limit would matter in clinical practice. It is usually assumed that the success proportion is the same in both groups unless there is good reason to believe that one treatment is, in fact, superior.
Statistical methods
Descriptive analyses: The investigators will use SPSS for statistical analysis. Yahya A. Acar, MD, will perform the analysis. Demographic data will be presented as frequencies and percentages. Continuous variables will be presented as mean and standard deviation.
Analyses used to assess: The chi-square test will be used for the comparison of two groups concerning categorical variables. Wilcoxon signed-rank test and the dependent t-test will be used for pairwise comparisons (first and last measurements) of continuous data that do not conform to a normal distribution. Logistic regression analysis will be used to identify factors independently predictive of success. Those factors remaining in the model will be used in a set of linear scores. Receiver operating characteristic curves (ROC) will be constructed for each model, and the areas under the curve will be calculated.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Virtual coaching group | Experimental | Other: Virtual coachIn this group, the virtual coach will train and assess. |
| Human instructor group | No intervention | –In this group, a human instructor will train, but the virtual coach will assess. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- >18 years of age
Key exclusion criteria (3 listed)
- i. not obtaining informed consent,
- ii. inability to complete all the procedures,
- iii. Completed a REBOA course iv. Used the US-guided REBOA simulator in any way
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Virtual coachThis group will be trained and assessed by the virtual coach. | Other | Virtual coaching group |
Primary outcome
Virtual coach is non-inferior in REBOA training to an average human instructor
Time frame: 2 hours
The study will compare the virtual coach group and human instructor groups by means of reaching to mastery. Mastery is defined as two consecutive successful REBOA insertion to zone 1 and zone 2. The investigators defined the success criteria in the methods section in detail.
3 secondary outcomes
Define the time required for a complete REBOA insertion on a simulator
Time frame: 2 minutes
Define the time required the time to mastery
Time frame: 2 hours
Association of success rates and complications on the simulator to spatial ability
Time frame: 8 minutes
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Nov 2025.
Related trials for Hemorrhage
Recruiting
Hemocoll, Avitene, or Bone Wax for Cancellous Bone Bleeding After Single-Ray Amputation
Hemostasis, Surgical Blood Loss
Active, not recruiting
Auricular VNS Following Subarachnoid Hemorrhage
Subarachnoid Hemorrhage
Not yet recruitingObservational study
Plaque and Bleeding on Probing Around Implants Supporting Fixed Full-Arch Dental Prostheses
Peri-Implant Health
RecruitingObservational study
Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH)
Subdural Hematoma, Subdural Hematoma, Chronic
RecruitingObservational study
INTERACT4 Expansion - Validation Study
Intracerebral Hemorrhage
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Samsun Lampotang study director
Univeristy of Florida
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Virtual coach in people with Hemorrhage and Simulation Training, run by University of Florida at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Virtual coach is non-inferior in REBOA training to an average human instructor (time frame: 2 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Nov 2025.